Study brain–skin links in teenagers with eczema
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at how eczema may be connected to the brain and sleep, using questionnaires and MRI scans. It may help researchers understand what drives symptoms and how treatments could be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 18 years old
- You have been diagnosed with atopic eczema by a skin specialist (dermatologist)
- You can join as someone needing treatment, or on topical treatment, or as a healthy control
- You can follow study instructions and complete questionnaires, in English
- You can safely have an MRI scan (no implanted metal devices; you can complete the scan)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special imaging to look at the structure of skin, comparing people with eczema (who have used steroid creams) to healthy volunteers. Researchers want to understand how the skin changes with eczema and its treatment.
This study follows adults with moderate to severe eczema who are eligible for or already taking systemic (pill or injection) medicines. It does not test any new drug—it simply tracks how eczema is managed in real life, which may help improve future care.
This study looks at the types of germs on the skin (skin microbiome) in healthy people and people with skin conditions, including atopic dermatitis (eczema). Researchers collect skin samples to understand how skin germs differ and how that may relate to skin health.
This study looks at why disease tends to be more severe in some people with atopic dermatitis (eczema), especially those with a specific genetic change in the IL-4 receptor (IL-4Ra). The results may help explain what drives flare-ups and could guide better treatments in the future.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This study looks at how people with atopic dermatitis (eczema) take part in clinical trials. It aims to understand what helps or hinders participation, so future trials can be more patient-friendly.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.